Metraipolis › archive › dc_bbc5ca3ad221

Risk of malignancy in patients with chronic kidney disease — Europe PMC PMID:35976968

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/35976968
DOI
10.1371/journal.pone.0272910
License (as archived)
CC0-1.0
Archived
2026-10-17T02:07:07.307Z
SHA-256 of the archived text
3316a8f1216c45fea8baf55cf8c4865c356077677a8f3530bd1cccc5810cfd2f
Stable URL of this page
https://metraipolis.com/documento/dc_bbc5ca3ad221

How to cite

Risk of malignancy in patients with chronic kidney disease — Europe PMC PMID:35976968 — Europe PMC (en), https://europepmc.org/article/MED/35976968 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_bbc5ca3ad221 (Metraipolis archive dc_bbc5ca3ad221, sha256 3316a8f1216c45fea8baf55cf8c4865c356077677a8f3530bd1cccc5810cfd2f)
BibTeX
@misc{dcbbc5ca3ad221,
  title = {Risk of malignancy in patients with chronic kidney disease — Europe PMC PMID:35976968},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/35976968},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_bbc5ca3ad221; sha256 3316a8f1216c45fea8baf55cf8c4865c356077677a8f3530bd1cccc5810cfd2f},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/35976968. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: Fifteen percent of US adults have chronic kidney disease (CKD). The effect of CKD on the development of different malignancies is unknown. Understanding the effect of CKD on the risk of development of cancer could have important implications for screening and early detection of cancer in these patients. Methods: Adult CKD patients [estimated GFR (eGFR) <60ml/min/1.73m2] between January 2001 and December 2020 were identified in this single institution study. Patients were divided into four stages of CKD by eGFR. The incidence of cancer and time to development of the first cancer were identified. Multivariable models were used to compare the overall cancer incidence while considering death as a competing risk event and adjusting for relevant covariates (sex, race, diabetes, hypertension, CAD, smoking or not, BMI, and CKD stages). Separate multivariable models of the incidence of cancers were conducted in each age group. Multivariable Cox models were used to fit the overall death adjusting for relevant covariates. Patients were censored at the conclusion of the study period (December 31, 2020). Statistical analysis was performed with SAS software (version 9.4). Results: Of the 13,750 patients with a diagnosis of CKD in this cohort, 2,758 (20.1%) developed a malignancy. The median time to development of cancer following a diagnosis of CKD was 8.5 years. Factors associated with the risk of developing cancer in CKD patients included increasing age, male sex and worsening chronic kidney disease, while diabetes was associated with a lower risk of malignancy. On multivariate analysis, the factors associated with increased mortality in patients who developed cancer included increasing age, diabetes and lower eGFR. Conclusion: CKD is an increased risk factor for the development of various malignancies. Age appropriate cancer screening should be aggressively pursued in those with progressive CKD.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2022 (prima pubblicazione 2022-08-17).
Identificativi: PMID 35976968 · PMCID PMC9385037 · DOI 10.1371/journal.pone.0272910.
Descrittori MeSH principali: Neoplasms; Diabetes Mellitus; Renal Insufficiency, Chronic.
Pagina: https://europepmc.org/article/MED/35976968 — https://doi.org/10.1371/journal.pone.0272910. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-17T01:37:22.925Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.